Hair loss drug showdown: which treatment works better?
NCT ID NCT07190534
Summary
This study aims to find out which of two commonly used medications works better for treating frontal fibrosing alopecia, a type of permanent scarring hair loss that mostly affects women. Fifty adult patients will choose to take either hydroxychloroquine or methotrexate and be followed for 48 weeks during their regular doctor visits. Researchers will measure changes in hair loss severity and quality of life to determine which treatment provides better results in everyday clinical practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRONTAL FIBROSING ALOPECIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Erasmus MC University Medical Center
Rotterdam, South Holland, 3015GD, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.